DMK Pharma Lands $3.2M Deal To Sell Drug In Ch. 11
Drugmaker DMK Pharmaceuticals Corp. informed a Delaware bankruptcy judge Monday that the debtor worked out a tentative agreement in its Chapter 11 case to sell an opioid overdose recovery treatment for...To view the full article, register now.
Already a subscriber? Click here to view full article